Skip to content
  • About
    • What we do
    • Our history
    • Our team
    • Our committees
    • Our partners
    • About genomics
  • Services
    • What we offer
    • Research we’re supporting
  • Tools & resources
    • Search all tools & resources
    • Research ethics & governance
    • Consent & patient support materials
    • Evaluating genomic research & translation
    • Data governance
    • Access our datasets
    • Data capture & standardisation
    • Data analysis & interpretation
    • Workforce education
    • Our publications
    • Our submissions
  • Our project areas
    • Our project areas
    • Genomic information management
    • Clinical genomic practice
    • Genomic literacy, workforce & training
    • Indigenous genomic priorities
    • Genomic diagnostics
    • Evaluating genomic research & translation
    • Australian health system policy & practice
    • Involvement & engagement
  • News & events
    • News
    • Events
    • Personal stories
    • Search news & events
  • Connect with us

The promise of whole genome sequencing for cheaper and more accurate diagnosis of common inherited kidney disease

Home All news & events News The promise of whole genome sequencing for…

A multidisciplinary team of researchers from the Garvan Institute of Medical Research, the Kinghorn Centre for Clinical Genomics, and St Vincent’s Hospital in Sydney, have found that Whole Genome Sequencing — where all of the genes of an individual are sequenced— yields a more accurate, and more cost-effective approach to diagnosing inherited kidney disease.

Dr Mallawaarachchi, a genomics researcher from the Garvan and co-lead of the study, shared the outcomes of the research at the KidGen Renal Genetics Symposium, held at the Royal Children’s Hospital in November 2016. The research focused on Autosomal Dominant Polycystic Kidney Disease (ADPKD), an inherited disorder in which cysts progressively expand and destroy the kidneys, eventually causing renal failure.

Through the application of Whole Genome Sequencing, the researchers were able to accurately diagnose ADPKD in 86% of study participants, compared with an accurate diagnosis in about 60% of cases when applying single-gene testing. The outcomes of the study hold promise for a new diagnostic test and improved clinical management for those with ADKPD.

See the full article at the Garvan Institute of Medical Research website, and access the research paper here.

 


More news

Couple with two young children, smiling at the baby on the mother's knee

Grants for Genomic Implementation Projects

Australian Genomics has funded eight new projects as part of its Genomic Implementation Projects grant...

May 30, 2022

Read More >

Mitochondrial cells

Mitochondrial donation now legal in Australia

The historic passing of the Mitochondrial Donation Law Reform (Maeve’s Law) Bill by the Australian...

March 31, 2022

Read More >

Group of young children with hands clasped together in the air

New national agency to advance genomic medicine welcomed

Australian Genomics Lead Professor Kathryn North says a new national agency to support genomic medicine...

March 20, 2022

Read More >


Connect with us

(03) 9936 6345
info@australiangenomics.org.au
50 Flemington Road, Parkville
Victoria 3052 Australia

In the spirit of reconciliation Australian Genomics acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.

To stay informed about our work, sign up to our newsletter

Subscribe

Quicklinks

  • Home
  • What we do
  • What we offer
  • Tools & resources
  • Our publications
  • Our project areas
  • Research we’re supporting
  • Our team

Privacy

  • We follow the Australian Privacy Principles
  • General privacy policy
  • Website privacy policies
  • Terms & conditions

Website by Blueboat.